Increasing Investigator Site Performance & Productivity
Brian York, Director, Feasibility and Patient Recruitment, Amgen
Regulatory Challenges and Expectations in Latin America and Asia Pacific to Effective Clinical Trial Development
Jerry Stewart, JD, MS, RPh, Associate Director, Global Regulatory Affairs, Asia-Pacific & Latin America, Wyeth Pharmaceuticals
Recruitment Planning Starts Earlier Than You Think
Katherine Valentine, Senior Manager, Clinical Trial Management, Clinical Operations, Genentech, Inc.
Global Regulatory Strategies for the Optimization of Modern Study Designs: Challenges of Using Placebo and Active Reference Products
Alex Kudrin, M.D., Ph.D., former Senior Manager, Global Clinical Development, GlaxoSmithKline Biologicals (Belgium)
Delivering Predictable Performance in Patient Recruitment
Alex Lancksweert, Director, Performance Metrics & Benchmarking, Global Clinical Operations, GlaxoSmithKline R&D
Increasing the Communication between the Sponsor and Investigational Sites to Facilitate Patient Recruitment and the Timely Collection of Quality Data
Matthew R. Dauphin, Associate Director, Global Clinical Programs, Clinical Research & Development, Shire Development Inc.
The Importance of Standardizing Study Coordinator Training: Essential Elements
April Bower, R.N., M.S., Health Program Specialist, National Center of Complementary and Alternative Medicine, Office of Clinical and Regulatory Affairs, National Institutes of Health
Current Challenges in Phase I Pediatric Research
Barry Mangum, PharmD, FCP, Associate Professor Clinical Pharmacology, Duke University Medical Center, Duke Clinical Research Institute
|